Synlico Inc.
BiotechnologyBiotechnology / Pharmaceutical Innovation
South San Francisco, CA
2021
founded
About
Synlico Inc. is an AI-powered drug discovery company dedicated to transforming traditional approaches in oncology through the development of engineered T cell therapies tailored to combat solid tumors. By harnessing advanced computational techniques, Synlico leads a paradigm shift in understanding and addressing the complexities of cellular behavior in the tumor microenvironment.
Company Values
Synlico stands out for its innovative integration of causality into drug design, enabling the engineering of therapies that are both more effective and tailored to the unique characteristics of individual patients' tumors.